Table 2 Effect of CurNPs and ZnONPs administration on fasting blood glucose, serum fasting insulin, HOMA-IR, HOMA-β, and AGEs levels of HFD/STZ-induced diabetic and control rats.
Groups | Fasting blood glucose (mg/dl) | Serum fasting insulin (µIU/ml) | HOMA-IR | HOMA-β | Serum AGEs (pg/ml) |
|---|---|---|---|---|---|
Control | 98.60 ± 1.03c | 24.30 ± 0.10e | 5.91 ± 0.06d | 246.64 ± 8.0 h | 11.33 ± 0.50d |
HFD/STZ | 481.00 ± 0.71a | 180.44 ± 0.43a | 214.30 ± 0.68a | 155.40 ± 0.39i | 26.21 ± 0.78a |
HFD/STZ-Cur | 109.20 ± 0.86b | 80.44 ± 0.15b | 21.68 ± 0.17b | 627.66 ± 11.68 g | 17.24 ± 0.51b,c |
HFD/STZ-CurNPs-10 | 75.00 ± 0.71e | 70.32 ± 0.20c | 13.02 ± 0.10c | 2140.85 ± 133.58b | 13.26 ± 0.65d |
HFD/STZ-CurNPs-50 | 79.80 ± 0.58d,e | 78.60 ± 0.31b | 15.48 ± 0.14c | 1692.45 ± 58.52d | 16.98 ± 0.37c |
HFD/STZ- ZnSO4 | 76.60 ± 0.93e | 66.99 ± 0.07d | 12.67 ± 0.15c | 1808.50 ± 128.84c | 19.43 ± 0.45b |
HFD/STZ-ZnONPs-10 | 98.00 ± 0.71c | 81.70 ± 0.20b | 19.76 ± 0.16b | 841.70 ± 17.00f. | 18.33 ± 0.37b |
HFD/STZ-ZnONPs-50 | 83.00 ± 0.71d | 77.96 ± 0.14b | 15.97 ± 0.12c | 1410.68 ± 51.42e | 15.01 ± 0.74c |
HFD/STZ-MT | 74.00 ± 0.71e | 71.26 ± 0.09c | 13.02 ± 0.13c | 2371.73 ± 154.84a | 20.33 ± 0.42b |